DOSSIER · 13F Holders · Q2 2026
VTGN
VISTAGEN THERAPEUTICS INC
56 institutions still hold VISTAGEN THERAPEUTICS INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 92840H400·56 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
56 institutions reported VTGN in Q2 2026. Commodore Capital LP leads at 20.1% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 3
36 more holders available. Log in →